Top 60 coronavirus treatments in the research pipeline

el coronavirus
Credit: Erica Yoon/ STAT

Anthony Fauci, MD, Director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), offered hope to the thousands of people with confirmed cases of COVID-19, and the millions around the world whose lives have been disrupted by the pandemic caused by SARS-CoV-2, when he expressed to a congressional panel [recently] his hope that the first patients would be dosed with vaccines in development for the novel coronavirus “in a few weeks.”

Despite that welcome development, it may take a while before vaccines and other treatments for COVID-19 reach patients who desperately need them.

ADVERTISEMENT

Those companies, and dozens of other drug developers and research institutions, are behind the 60 active drug development programs in North America, Europe, and China that are highlighted by GEN in this updated A-List. More than two dozen of these treatments have emerged or been made public just in the two weeks since GEN published its original A-List summarizing COVID-19 therapies in the works, How to Conquer Coronavirus: Top 35 Treatments in Development.

Related article:  'A misunderstanding': WHO backtracks on claim that asymptomatic transmission of the coronavirus is 'very rare'

Each prospective treatment is listed in alphabetical order by its developer(s), followed by the treatment name or description, the type of treatment including its mechanism, and a brief status update summarizing recent developments.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend